These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 18057181

  • 1. A novel, killed-virus nasal vaccinia virus vaccine.
    Bielinska AU, Chepurnov AA, Landers JJ, Janczak KW, Chepurnova TS, Luker GD, Baker JR.
    Clin Vaccine Immunol; 2008 Feb; 15(2):348-58. PubMed ID: 18057181
    [Abstract] [Full Text] [Related]

  • 2. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.
    Berhanu A, Wilson RL, Kirkwood-Watts DL, King DS, Warren TK, Lund SA, Brown LL, Krupkin AK, Vandermay E, Weimers W, Honeychurch KM, Grosenbach DW, Jones KF, Hruby DE.
    J Virol; 2008 Apr; 82(7):3517-29. PubMed ID: 18199639
    [Abstract] [Full Text] [Related]

  • 3. Immune responses to the smallpox vaccine given in combination with ST-246, a small-molecule inhibitor of poxvirus dissemination.
    Grosenbach DW, Jordan R, King DS, Berhanu A, Warren TK, Kirkwood-Watts DL, Tyavanagimatt S, Tan Y, Wilson RL, Jones KF, Hruby DE.
    Vaccine; 2008 Feb 13; 26(7):933-46. PubMed ID: 18226434
    [Abstract] [Full Text] [Related]

  • 4. Protection of mice against the highly pathogenic VVIHD-J by DNA and fowlpox recombinant vaccines, administered by electroporation and intranasal routes, correlates with serum neutralizing activity.
    Bissa M, Quaglino E, Zanotto C, Illiano E, Rolih V, Pacchioni S, Cavallo F, De Giuli Morghen C, Radaelli A.
    Antiviral Res; 2016 Oct 13; 134():182-191. PubMed ID: 27637905
    [Abstract] [Full Text] [Related]

  • 5. Antibodies Induced by Smallpox Vaccination after at Least 45 Years Cross-React with and In Vitro Neutralize Mpox Virus: A Role for Polyclonal B Cell Activation?
    Mariotti S, Venturi G, Chiantore MV, Teloni R, De Santis R, Amendola A, Fortuna C, Marsili G, Grilli G, Lia MS, Kiros ST, Lagi F, Bartoloni A, Iacobino A, Cresta R, Lastilla M, Biselli R, Di Bonito P, Lista F, Nisini R.
    Viruses; 2024 Apr 17; 16(4):. PubMed ID: 38675961
    [Abstract] [Full Text] [Related]

  • 6. Systemically administered DNA and fowlpox recombinants expressing four vaccinia virus genes although immunogenic do not protect mice against the highly pathogenic IHD-J vaccinia strain.
    Bissa M, Pacchioni SM, Zanotto C, De Giuli Morghen C, Illiano E, Granucci F, Zanoni I, Broggi A, Radaelli A.
    Virus Res; 2013 Dec 26; 178(2):374-82. PubMed ID: 24050999
    [Abstract] [Full Text] [Related]

  • 7. Single-shot immunization with recombinant adenovirus encoding vaccinia virus glycoprotein A27L is protective against a virulent respiratory poxvirus infection.
    Rudraraju R, Ramsay AJ.
    Vaccine; 2010 Jul 12; 28(31):4997-5004. PubMed ID: 20653083
    [Abstract] [Full Text] [Related]

  • 8. Mucosal immunization induces a higher level of lasting neutralizing antibody response in mice by a replication-competent smallpox vaccine: vaccinia Tiantan strain.
    Lu B, Yu W, Huang X, Wang H, Liu L, Chen Z.
    J Biomed Biotechnol; 2011 Jul 12; 2011():970424. PubMed ID: 21765641
    [Abstract] [Full Text] [Related]

  • 9. Differential antigen requirements for protection against systemic and intranasal vaccinia virus challenges in mice.
    Kaufman DR, Goudsmit J, Holterman L, Ewald BA, Denholtz M, Devoy C, Giri A, Grandpre LE, Heraud JM, Franchini G, Seaman MS, Havenga MJ, Barouch DH.
    J Virol; 2008 Jul 12; 82(14):6829-37. PubMed ID: 18448519
    [Abstract] [Full Text] [Related]

  • 10. Intranasal immunization with recombinant Vaccinia virus Tiantan harboring Zaire Ebola virus gp elicited systemic and mucosal neutralizing antibody in mice.
    Xie L, Zai J, Yi K, Li Y.
    Vaccine; 2019 May 31; 37(25):3335-3342. PubMed ID: 31076161
    [Abstract] [Full Text] [Related]

  • 11. The persistence of humoral and cellular immunities more than three decades after smallpox vaccination.
    Kim SH, Yeo SG, Park KH, Bang JW, Kim HB, Kim NJ, Jee Y, Cho H, Oh MD, Choe KW.
    Clin Microbiol Infect; 2007 Jan 31; 13(1):91-3. PubMed ID: 17184294
    [Abstract] [Full Text] [Related]

  • 12. Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigens.
    Sakhatskyy P, Wang S, Zhang C, Chou TH, Kishko M, Lu S.
    Virology; 2008 Feb 05; 371(1):98-107. PubMed ID: 17950773
    [Abstract] [Full Text] [Related]

  • 13. Smallpox vaccine, ACAM2000: Sites and duration of viral shedding and effect of povidone iodine on scarification site shedding and immune response.
    Pittman PR, Garman PM, Kim SH, Schmader TJ, Nieding WJ, Pike JG, Knight R, Johnston SC, Huggins JW, Kortepeter MG, Korman L, Ranadive M, Quinn X, Meyers MS.
    Vaccine; 2015 Jun 12; 33(26):2990-6. PubMed ID: 25930115
    [Abstract] [Full Text] [Related]

  • 14. Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge.
    Hooper JW, Golden JW, Ferro AM, King AD.
    Vaccine; 2007 Feb 26; 25(10):1814-23. PubMed ID: 17240007
    [Abstract] [Full Text] [Related]

  • 15. Determination of immunity to vaccinia virus by using diluted inactivated vaccinia vaccine solution for skin testing.
    Somekh E, Smetana Z, Tanay A, Dalal I, Babai I, Mendelson E.
    Vaccine; 2004 Dec 02; 23(3):321-4. PubMed ID: 15530675
    [Abstract] [Full Text] [Related]

  • 16. Impact of ST-246® on ACAM2000™ smallpox vaccine reactogenicity, immunogenicity, and protective efficacy in immunodeficient mice.
    Berhanu A, King DS, Mosier S, Jordan R, Jones KF, Hruby DE, Grosenbach DW.
    Vaccine; 2010 Dec 16; 29(2):289-303. PubMed ID: 21036130
    [Abstract] [Full Text] [Related]

  • 17. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
    Meseda CA, Garcia AD, Kumar A, Mayer AE, Manischewitz J, King LR, Golding H, Merchlinsky M, Weir JP.
    Virology; 2005 Sep 01; 339(2):164-75. PubMed ID: 15993917
    [Abstract] [Full Text] [Related]

  • 18. Identification of protective T-cell antigens for smallpox vaccines.
    Ando J, Ngo MC, Ando M, Leen A, Rooney CM.
    Cytotherapy; 2020 Nov 01; 22(11):642-652. PubMed ID: 32747299
    [Abstract] [Full Text] [Related]

  • 19. Safety, immunogenicity and protective efficacy in mice of a new cell-cultured Lister smallpox vaccine candidate.
    Ferrier-Rembert A, Drillien R, Meignier B, Garin D, Crance JM.
    Vaccine; 2007 Nov 28; 25(49):8290-7. PubMed ID: 17964011
    [Abstract] [Full Text] [Related]

  • 20. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
    Bielinska AU, Janczak KW, Landers JJ, Makidon P, Sower LE, Peterson JW, Baker JR.
    Infect Immun; 2007 Aug 28; 75(8):4020-9. PubMed ID: 17502384
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.